CCM
GCVRZ

Cribstone Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Cribstone Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-70
Closed – – 917
2017
Q3 		$0 Hold
70
– – ﹤0.01% 771
2017
Q2 		$0 Hold
70
– – ﹤0.01% 770
2017
Q1 		$0 Hold
70
– – ﹤0.01% 780
2016
Q4 		$0 Hold
70
– – ﹤0.01% 744
2016
Q3 		$0 Hold
70
– – ﹤0.01% 755
2016
Q2 		$0 Buy
+70
New +$12 ﹤0.01% 742

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Cribstone Capital Management's GCVRZ Position: Q4 2017 in Review

Cribstone Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2017, closing a stake of 70 shares.

Cribstone Capital Management first reported a position in GCVRZ in Q2 2016 and held it in 6 quarters. The position peaked at $0 in Q3 2017. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2017.

  • Cribstone Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
  • Cribstone Capital Management sold 70 Sanofi Contingent Value Rights shares in Q4 2017.
  • Cribstone Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2016 and held it in 6 quarters.
  • Cribstone Capital Management's Sanofi Contingent Value Rights position peaked at $0 in Q3 2017.
  • 105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2017.

Based on Cribstone Capital Management's 13F filing for Q4 2017, filed 2 Feb 2018.